Jaguar Animal Health Inc Total Assets
Jaguar Animal Health Inc total assets. Based on the latest financial reports, Jaguar Animal Health Inc (JAGX) holds total assets worth $34.19 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see JAGX market cap for the company's overall valuation and market capitalisation.
Total Assets of Jaguar Animal Health Inc (2007–2025)
Total assets of Jaguar Animal Health Inc from 2007 to 2025. This chart illustrates how Jaguar Animal Health Inc's total assets have evolved over time, based on quarterly financial data. See current stock price of Jaguar Animal Health Inc for real-time trading data and today's change.
Jaguar Animal Health Inc - Asset Composition Analysis
Jaguar Animal Health Inc Total Assets Breakdown (December 2025)
Jaguar Animal Health Inc total assets breakdown as of December 2025. Jaguar Animal Health Inc's total assets of $34.19 Million consist of 53.1% current assets and 46.9% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 2.5% |
| Accounts Receivable | $1.70 Million | 4.4% |
| Inventory | $8.60 Million | 22.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $16.02 Million | 41.8% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2007–2025)
This chart illustrates how Jaguar Animal Health Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Jaguar Animal Health Inc short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Jaguar Animal Health Inc's current assets represent 53.1% of total assets in 2025, a decrease from 79.4% in 2007.
- Cash Position: Cash and equivalents constituted 2.5% of total assets in 2025, down from 14.6% in 2007.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 41.0% of total assets, an increase from 14.0% in 2007.
- Asset Diversification: The largest asset category is intangible assets at 41.8% of total assets.
Jaguar Animal Health Inc Competitors by Total Assets
Key competitors of Jaguar Animal Health Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
argenx NV ADR
NASDAQ:ARGX
|
USA | $10.03 Billion |
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Tubize-Fin
BR:TUB
|
Belgium | €1.99 Billion |
|
Ascendis Pharma AS
NASDAQ:ASND
|
USA | $2.01 Billion |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
USA | $1.26 Billion |
|
3SBio Inc
F:83B
|
Germany | €36.25 Billion |
|
Galapagos N.V.
AS:GLPG
|
Netherlands | €3.37 Billion |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥28.15 Billion |
Jaguar Animal Health Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 0.69 | 0.95 | 2.01 |
| Quick Ratio | 0.40 | 0.59 | 1.63 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $-7.85 Million | $-1.31 Million | $12.05 Million |
Jaguar Animal Health Inc - Advanced Valuation Insights
This section examines the relationship between Jaguar Animal Health Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 0.70 |
| Latest Market Cap to Assets Ratio | 0.02 |
| Asset Growth Rate (YoY) | -28.3% |
| Total Assets | $38.32 Million |
| Market Capitalization | $786.58K USD |
Valuation Analysis
Below Book Valuation: The market values Jaguar Animal Health Inc's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.
Significant Asset Reduction: Jaguar Animal Health Inc's assets decreased by 28.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Jaguar Animal Health Inc (2007–2025)
The table below shows the annual total assets of Jaguar Animal Health Inc from 2007 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $38.32 Million | -28.27% |
| 2024-12-31 | $53.42 Million | +5.24% |
| 2023-12-31 | $50.76 Million | +6.98% |
| 2022-12-31 | $47.45 Million | -10.91% |
| 2021-12-31 | $53.27 Million | +24.33% |
| 2020-12-31 | $42.84 Million | +17.67% |
| 2019-12-31 | $36.41 Million | -11.29% |
| 2018-12-31 | $41.04 Million | -5.93% |
| 2017-12-31 | $43.63 Million | +1124.46% |
| 2016-12-31 | $3.56 Million | -71.28% |
| 2015-12-31 | $12.41 Million | +115.49% |
| 2014-12-31 | $5.76 Million | +1890.12% |
| 2013-12-31 | $289.26K | -97.19% |
| 2007-12-31 | $10.30 Million | -- |
About Jaguar Animal Health Inc
Jaguar Health, Inc., a commercial-stage pharmaceuticals company, focuses on developing plant-based prescription medicines for people and animals with gastrointestinal distress. It operates through two segments, Animal Health and Human Health. The company focuses on developing and commercializing prescription and non-prescription products for companion and production animals; and human products. I… Read more